TreeWAS – Variant ID: rs914715

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K35.9 Acute appendicitis, unspecified	0.000	0.789	0.211
K35 Acute appendicitis	0.000	0.797	0.203
K35-K38 Diseases of appendix	0.000	0.808	0.192
K38 Other diseases of appendix	0.000	0.816	0.184
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.818	0.182
K37 Unspecified appendicitis	0.000	0.821	0.179
K38.8 Other specified diseases of appendix	0.000	0.824	0.176
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.842	0.158
K35.1 Acute appendicitis with peritoneal abscess	0.000	0.845	0.155
K38.9 Disease of appendix, unspecified	0.000	0.859	0.141
K38.2 Diverticulum of appendix	0.000	0.863	0.137
K36 Other appendicitis	0.000	0.864	0.136
K38.1 Appendicular concretions	0.000	0.865	0.135
K38.3 Fistula of appendix	0.000	0.868	0.132
K38.0 Hyperplasia of appendix	0.000	0.872	0.128
K35.3 Acute appendicitis with localized peritonitis	0.000	0.876	0.124
K35.8 Acute appendicitis, other and unspecified	0.000	0.880	0.120
Z96.6 Presence of orthopaedic joint implants	0.068	0.932	0.000
Z45.8 Adjustment and management of other implanted devices	0.023	0.977	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.984	0.016
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.987	0.013
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.989	0.011
Z45 Adjustment and management of implanted device	0.011	0.989	0.000
E10.3 With ophthalmic complications	0.000	0.990	0.010
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.990	0.010
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.990	0.010
Z45.0 Adjustment and management of cardiac pacemaker	0.009	0.991	0.000
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.991	0.009
E10 Insulin-dependent diabetes mellitus	0.000	0.991	0.009
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.991	0.009
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.991	0.009
E10.1 With ketoacidosis	0.000	0.991	0.009
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.991	0.008
Z45.2 Adjustment and management of vascular access device	0.008	0.992	0.000
E10.9 Without complications	0.000	0.992	0.008
E10.2 With renal complications	0.000	0.992	0.008
Z45.3 Adjustment and management of implanted hearing device	0.008	0.992	0.000
E10.4 With neurological complications	0.000	0.992	0.008
Z45.9 Adjustment and management of unspecified implanted device	0.007	0.993	0.000
Z45.1 Adjustment and management of infusion pump	0.007	0.993	0.000
E10.0 With coma	0.000	0.993	0.007
M47.86 Other spondylosis (Lumbar region)	0.007	0.993	0.000
E10.7 With multiple complications	0.000	0.993	0.007
E10.5 With peripheral circulatory complications	0.000	0.993	0.007
M47.82 Other spondylosis (Cervical region)	0.006	0.994	0.000
M47.8 Other spondylosis	0.006	0.994	0.000
E10.8 With unspecified complications	0.000	0.994	0.006
O94-O99 Other obstetric conditions, not elsewhere classified	0.000	0.994	0.006
E10.6 With other specified complications	0.000	0.994	0.006
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.994	0.006
G91.9 Hydrocephalus, unspecified	0.000	0.994	0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.994	0.006
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.995	0.005
M47 Spondylosis	0.005	0.995	0.000
G91 Hydrocephalus	0.000	0.995	0.005
M47.83 Other spondylosis (Cervicothoracic region)	0.005	0.995	0.000
T42.4 Benzodiazepines	0.000	0.995	0.005
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
M47.85 Other spondylosis (Thoracolumbar region)	0.005	0.995	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.005	0.995	0.000
M47.89 Other spondylosis (Site unspecified)	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
M47.1 Other spondylosis with myelopathy	0.005	0.995	0.000
T42.1 Iminostilbenes	0.000	0.995	0.005
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.005	0.995	0.000
O97 Death from sequelae of direct obstetric causes	0.000	0.995	0.005
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.000	0.995	0.005
O95 Obstetric death of unspecified cause	0.000	0.995	0.005
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.000	0.995	0.005
N81.5 Vaginal enterocele	0.000	0.995	0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.995	0.005
T42.0 Hydantoin derivatives	0.000	0.995	0.005
G91.2 Normal-pressure hydrocephalus	0.000	0.995	0.005
M47.84 Other spondylosis (Thoracic region)	0.004	0.995	0.000
L91.8 Other hypertrophic disorders of skin	0.000	0.996	0.004
Z48.0 Attention to surgical dressings and sutures	0.004	0.996	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.004	0.996	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.004	0.996	0.000
M45-M49 Spondylopathies	0.004	0.996	0.000
G91.0 Communicating hydrocephalus	0.000	0.996	0.004
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.004
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.004
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
T42.3 Barbiturates	0.000	0.996	0.004
M48 Other spondylopathies	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.996	0.004
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
Z48.8 Other specified surgical follow-up care	0.004	0.996	0.000
M47.0 Anterior spinal and vertebral artery compression syndromes	0.004	0.996	0.000
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.004	0.996	0.000
G91.8 Other hydrocephalus	0.000	0.996	0.004
G90-G99 Other disorders of the nervous system	0.000	0.996	0.004
M46.9 Inflammatory spondylopathy, unspecified	0.004	0.996	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
M48.0 Spinal stenosis	0.004	0.996	0.000
M47.2 Other spondylosis with radiculopathy	0.004	0.996	0.000
M46 Other inflammatory spondylopathies	0.004	0.996	0.000
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.996	0.004
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.004	0.996	0.000
G91.1 Obstructive hydrocephalus	0.000	0.996	0.004
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.996	0.004
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.004
T50.5 Appetite depressants	0.000	0.996	0.004
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.996	0.004
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.004
T50.0 Mineralocorticoids and their antagonists	0.000	0.996	0.004
G96 Other disorders of central nervous system	0.000	0.996	0.004
T50.8 Diagnostic agents	0.000	0.996	0.004
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.004
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.004	0.996	0.000
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.004	0.996	0.000
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.004	0.996	0.000
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.004	0.996	0.000
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.004	0.996	0.000
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.004	0.996	0.000
Z96 Presence of other functional implants	0.004	0.996	0.000
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.000	0.996	0.003
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.004	0.996	0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.000	0.996	0.004
O96.9 Death from unspecified obstetric cause	0.000	0.996	0.003
O96.1 Death from indirect obstetric cause	0.000	0.996	0.003
O96.0 Death from direct obstetric cause	0.000	0.996	0.003
O97.9 Death from sequelae of obstetric cause, unspecified	0.000	0.996	0.003
O97.1 Death from sequelae of indirect obstetric cause	0.000	0.996	0.003
O97.0 Death from sequelae of direct obstetric cause	0.000	0.996	0.003
G96.0 Cerebrospinal fluid leak	0.000	0.996	0.004
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.004	0.996	0.000
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.000	0.996	0.004
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.004
M48.06 Spinal stenosis (Lumbar region)	0.004	0.996	0.000
Z48 Other surgical follow-up care	0.004	0.996	0.000
M48.04 Spinal stenosis (Thoracic region)	0.003	0.996	0.000
M48.8 Other specified spondylopathies	0.003	0.996	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.000	0.996	0.003
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.003	0.997	0.000
G90 Disorders of autonomic nervous system	0.000	0.997	0.003
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.003	0.997	0.000
G97.8 Other postprocedural disorders of nervous system	0.000	0.997	0.003
M48.9 Spondylopathy, unspecified	0.003	0.997	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
G98 Other disorders of nervous system, not elsewhere classified	0.000	0.997	0.003
M49 Spondylopathies in diseases classified elsewhere	0.003	0.997	0.000
M45 Ankylosing spondylitis	0.003	0.997	0.000
G94 Other disorders of brain in diseases classified elsewhere	0.000	0.997	0.003
M47.92 Spondylosis, unspecified (Cervical region)	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M47.9 Spondylosis, unspecified	0.003	0.997	0.000
M48.4 Fatigue fracture of vertebra	0.003	0.997	0.000
M48.3 Traumatic spondylopathy	0.003	0.997	0.000
M48.2 Kissing spine	0.003	0.997	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.003	0.997	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.003	0.997	0.000
G90.3 Multisystem degeneration	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
M48.05 Spinal stenosis (Thoracolumbar region)	0.003	0.997	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.003	0.997	0.000
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)	0.003	0.997	0.000
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)	0.003	0.997	0.000
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)	0.003	0.997	0.000
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)	0.003	0.997	0.000
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)	0.003	0.997	0.000
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)	0.003	0.997	0.000
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)	0.003	0.997	0.000
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)	0.003	0.997	0.000
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)	0.003	0.997	0.000
G92 Toxic encephalopathy	0.000	0.997	0.003
M48.07 Spinal stenosis (Lumbosacral region)	0.003	0.997	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.003	0.997	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.003	0.997	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.003	0.997	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.003	0.997	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.997	0.003
M46.0 Spinal enthesopathy	0.003	0.997	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.997	0.003
M48.03 Spinal stenosis (Cervicothoracic region)	0.003	0.997	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.003	0.997	0.000
Z96.9 Presence of functional implant, unspecified	0.003	0.997	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.000	0.997	0.003
G96.9 Disorder of central nervous system, unspecified	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.003	0.997	0.000
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.003	0.997	0.000
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.003	0.997	0.000
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.003	0.997	0.000
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.003	0.997	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.000	0.997	0.003
M46.3 Infection of intervertebral disk (pyogenic)	0.003	0.997	0.000
M46.8 Other specified inflammatory spondylopathies	0.003	0.997	0.000
M46.5 Other infective spondylopathies	0.003	0.997	0.000
G96.8 Other specified disorders of central nervous system	0.000	0.997	0.003
M48.5 Collapsed vertebra, not elsewhere classified	0.003	0.997	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.003	0.997	0.000
M46.1 Sacro-iliitis, not elsewhere classified	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
G96.1 Disorders of meninges, not elsewhere classified	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.003	0.997	0.000
Z96.3 Presence of artificial larynx	0.003	0.997	0.000
M46.4 Discitis, unspecified	0.003	0.997	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.003	0.997	0.000
M48.87 Other specified spondylopathies (Lumbosacral region)	0.003	0.997	0.000
G97.9 Postprocedural disorder of nervous system, unspecified	0.000	0.997	0.003
G97.2 Intracranial hypotension following ventricular shunting	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
Z96.5 Presence of tooth-root and mandibular implants	0.003	0.997	0.000
G94.1 Hydrocephalus in neoplastic disease	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
M48.82 Other specified spondylopathies (Cervical region)	0.003	0.997	0.000
M48.96 Spondylopathy, unspecified (Lumbar region)	0.003	0.997	0.000
Z96.4 Presence of endocrine implants	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
M48.02 Spinal stenosis (Cervical region)	0.003	0.997	0.000
M48.89 Other specified spondylopathies (Site unspecified)	0.003	0.997	0.000
M48.92 Spondylopathy, unspecified (Cervical region)	0.003	0.997	0.000
T40.5 Cocaine	0.000	0.997	0.003
L91 Hypertrophic disorders of skin	0.000	0.997	0.003
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.003	0.997	0.000
M48.84 Other specified spondylopathies (Thoracic region)	0.003	0.997	0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.003	0.997	0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.003	0.997	0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.003	0.997	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.000	0.997	0.003
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.000	0.997	0.003
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.003	0.997	0.000
G62.8 Other specified polyneuropathies	0.003	0.997	0.000
G90.4 Autonomic dysreflexia	0.000	0.997	0.003
G90.1 Familial dysautonomia [Riley-Day]	0.000	0.997	0.003
G95 Other diseases of spinal cord	0.000	0.997	0.003
M48.86 Other specified spondylopathies (Lumbar region)	0.003	0.997	0.000
M49.5 Collapsed vertebra in diseases classified elsewhere	0.003	0.997	0.000
Z48.9 Surgical follow-up care, unspecified	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.003	0.997	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.003	0.997	0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.003	0.997	0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.003	0.997	0.000
M48.94 Spondylopathy, unspecified (Thoracic region)	0.003	0.997	0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.003	0.997	0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.003	0.997	0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.003	0.997	0.000
G97.0 Cerebrospinal fluid leak from spinal puncture	0.000	0.997	0.003
M45.X6 Ankylosing spondylitis (Lumbar region)	0.003	0.997	0.000
M48.09 Spinal stenosis (Site unspecified)	0.003	0.997	0.000
M46.2 Osteomyelitis of vertebra	0.002	0.997	0.000
O26.8 Other specified pregnancy-related conditions	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.000	0.997	0.003
L91.0 Keloid scar	0.000	0.997	0.003
M49.8 Spondylopathy in other diseases classified elsewhere	0.003	0.997	0.000
M49.4 Neuropathic spondylopathy	0.003	0.997	0.000
M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
M49.2 Enterobacterial spondylitis	0.003	0.997	0.000
M49.1 Brucella spondylitis	0.003	0.997	0.000
M49.0 Tuberculosis of spine	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.000	0.997	0.003
Z89.4 Acquired absence of foot and ankle	0.000	0.997	0.003
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.003	0.997	0.000
G90.8 Other disorders of autonomic nervous system	0.000	0.997	0.003
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.003	0.997	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.003	0.997	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.003	0.997	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
M48.99 Spondylopathy, unspecified (Site unspecified)	0.002	0.997	0.000
S62.60 Fracture of other finger (closed)	0.003	0.997	0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.000	0.997	0.002
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.002
G90.9 Disorder of autonomic nervous system, unspecified	0.000	0.997	0.002
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.002	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
T47.7 Emetics	0.000	0.997	0.002
T47.5 Digestants	0.000	0.997	0.002
T47.3 Saline and osmotic laxatives	0.000	0.997	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.002
G94.2 Hydrocephalus in other diseases classified elsewhere	0.000	0.997	0.002
M45.X2 Ankylosing spondylitis (Cervical region)	0.002	0.997	0.000
T40.3 Methadone	0.000	0.997	0.002
T40.2 Other opioids	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.002
M46.06 Spinal enthesopathy (Lumbar region)	0.002	0.997	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.002	0.997	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.002	0.997	0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.002	0.997	0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.002	0.997	0.000
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.002	0.997	0.000
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.002	0.997	0.000
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.002	0.997	0.000
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.002	0.997	0.000
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.002	0.997	0.000
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.002	0.997	0.000
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.002	0.997	0.000
M48.29 Kissing spine (Site unspecified)	0.002	0.997	0.000
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M48.27 Kissing spine (Lumbosacral region)	0.002	0.997	0.000
M48.26 Kissing spine (Lumbar region)	0.002	0.997	0.000
M48.25 Kissing spine (Thoracolumbar region)	0.002	0.997	0.000
M48.24 Kissing spine (Thoracic region)	0.002	0.997	0.000
M48.23 Kissing spine (Cervicothoracic region)	0.002	0.997	0.000
M48.22 Kissing spine (Cervical region)	0.002	0.997	0.000
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.002	0.997	0.000
M48.20 Kissing spine (Multiple sites in spine)	0.002	0.997	0.000
M48.39 Traumatic spondylopathy (Site unspecified)	0.002	0.997	0.000
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.002	0.997	0.000
M48.36 Traumatic spondylopathy (Lumbar region)	0.002	0.997	0.000
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.002	0.997	0.000
M48.34 Traumatic spondylopathy (Thoracic region)	0.002	0.997	0.000
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.002	0.997	0.000
M48.32 Traumatic spondylopathy (Cervical region)	0.002	0.997	0.000
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.002	0.997	0.000
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.002	0.997	0.000
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.002	0.997	0.000
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.002	0.997	0.000
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.002	0.997	0.000
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.002	0.997	0.000
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.002	0.997	0.000
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.002	0.997	0.000
M48.42 Fatigue fracture of vertebra (Cervical region)	0.002	0.997	0.000
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.002	0.997	0.000
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.002	0.997	0.000
E16.2 Hypoglycaemia, unspecified	0.003	0.997	0.000
G95.1 Vascular myelopathies	0.000	0.997	0.003
Z96.2 Presence of otological and audiological implants	0.002	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
T36.6 Rifamycins	0.000	0.997	0.002
T36.5 Aminoglycosides	0.000	0.997	0.002
T36.2 Chloramphenicol group	0.000	0.997	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.002
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.002	0.997	0.000
T36.3 Macrolides	0.000	0.997	0.002
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ	0.002	0.997	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.002	0.997	0.000
M46.09 Spinal enthesopathy (Site unspecified)	0.002	0.997	0.000
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M46.07 Spinal enthesopathy (Lumbosacral region)	0.002	0.997	0.000
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.002	0.997	0.000
M46.04 Spinal enthesopathy (Thoracic region)	0.002	0.997	0.000
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.002	0.997	0.000
M46.02 Spinal enthesopathy (Cervical region)	0.002	0.997	0.000
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.002	0.997	0.000
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.002	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.002
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.002	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.002
T47.4 Other laxatives	0.000	0.997	0.002
M47.94 Spondylosis, unspecified (Thoracic region)	0.002	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.002
T37.5 Antiviral drugs	0.000	0.997	0.002
T37.4 Anthelminthics	0.000	0.997	0.002
T37.3 Other antiprotozoal drugs	0.000	0.997	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.002
T37.1 Antimycobacterial drugs	0.000	0.997	0.002
T37.0 Sulphonamides	0.000	0.997	0.002
N86 Erosion and ectropion of cervix uteri	0.000	0.997	0.003
M46.34 Infection of intervertebral disc (pyogenic) (Thoracic region)	0.002	0.997	0.000
M46.49 Discitis, unspecified (Site unspecified)	0.002	0.997	0.000
T36.4 Tetracyclines	0.000	0.997	0.002
M46.39 Infection of intervertebral disc (pyogenic) (Site unspecified)	0.002	0.997	0.000
M46.38 Infection of intervertebral disc (pyogenic) (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M46.37 Infection of intervertebral disc (pyogenic) (Lumbosacral region)	0.002	0.997	0.000
M46.36 Infection of intervertebral disc (pyogenic) (Lumbar region)	0.002	0.997	0.000
M46.35 Infection of intervertebral disc (pyogenic) (Thoracolumbar region)	0.002	0.997	0.000
M46.33 Infection of intervertebral disc (pyogenic) (Cervicothoracic region)	0.002	0.997	0.000
M46.32 Infection of intervertebral disc (pyogenic) (Cervical region)	0.002	0.997	0.000
M46.31 Infection of intervertebral disc (pyogenic) (Occipito-atlanto-axial region)	0.002	0.997	0.000
M46.30 Infection of intervertebral disc (pyogenic) (Multiple sites in spine)	0.002	0.997	0.000
M46.59 Other infective spondylopathies (Site unspecified)	0.002	0.997	0.000
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M46.57 Other infective spondylopathies (Lumbosacral region)	0.002	0.997	0.000
M46.56 Other infective spondylopathies (Lumbar region)	0.002	0.997	0.000
M46.55 Other infective spondylopathies (Thoracolumbar region)	0.002	0.997	0.000
M46.54 Other infective spondylopathies (Thoracic region)	0.002	0.997	0.000
M46.53 Other infective spondylopathies (Cervicothoracic region)	0.002	0.997	0.000
M46.52 Other infective spondylopathies (Cervical region)	0.002	0.997	0.000
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)	0.002	0.997	0.000
M46.50 Other infective spondylopathies (Multiple sites in spine)	0.002	0.997	0.000
M46.89 Other specified inflammatory spondylopathies (Site unspecified)	0.002	0.997	0.000
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)	0.002	0.997	0.000
M46.86 Other specified inflammatory spondylopathies (Lumbar region)	0.002	0.997	0.000
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)	0.002	0.997	0.000
M46.84 Other specified inflammatory spondylopathies (Thoracic region)	0.002	0.997	0.000
M46.83 Other specified inflammatory spondylopathies (Cervicothoracic region)	0.002	0.997	0.000
M46.82 Other specified inflammatory spondylopathies (Cervical region)	0.002	0.997	0.000
M46.81 Other specified inflammatory spondylopathies (Occipito-atlanto-axial region)	0.002	0.997	0.000
M46.80 Other specified inflammatory spondylopathies (Multiple sites in spine)	0.002	0.997	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.002	0.997	0.000
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.002	0.997	0.000
T40.6 Other and unspecified narcotics	0.000	0.997	0.002
Z96.8 Presence of other specified functional implants	0.002	0.997	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.002	0.998	0.000
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.002	0.998	0.000
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.002	0.998	0.000
Z89.5 Acquired absence of leg at or below knee	0.000	0.998	0.002
M46.16 Sacroiliitis, not elsewhere classified-Lumbar	0.002	0.998	0.000
M46.15 Sacroiliitis, not elsewhere classified-Thoracolumbar	0.002	0.998	0.000
M46.14 Sacroiliitis, not elsewhere classified-Thoracic	0.002	0.998	0.000
M46.13 Sacroiliitis, not elsewhere classified-Cervicothoracic	0.002	0.998	0.000
M46.12 Sacroiliitis, not elsewhere classified-Cervical	0.002	0.998	0.000
M46.11 Sacroiliitis, not elsewhere classified-Occipit-atl-axl	0.002	0.998	0.000
M46.10 Sacroiliitis, not elsewhere classified-Mult site	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.002	0.998	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
M46.44 Discitis, unspecified (Thoracic region)	0.002	0.998	0.000
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
M46.48 Discitis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.47 Discitis, unspecified (Lumbosacral region)	0.002	0.998	0.000
M46.45 Discitis, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M46.43 Discitis, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M46.41 Discitis, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.40 Discitis, unspecified (Multiple sites in spine)	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
M46.19 Sacroiliitis, not elsewhere classified-Site unspe	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
Z96.7 Presence of other bone and tendon implants	0.002	0.998	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
M46.17 Sacroiliitis, not elsewhere classified-Lumbosacral	0.002	0.998	0.000
M46.42 Discitis, unspecified (Cervical region)	0.002	0.998	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
Z89 Acquired absence of limb	0.000	0.998	0.002
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
G90.2 Horner's syndrome	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
S62.61 Fracture of other finger (open)	0.002	0.998	0.000
M47.99 Spondylosis, unspecified (Site unspecified)	0.002	0.998	0.000
M49.56 Collapsed vertebra in diseases classified elsewhere (Lumbar region)	0.002	0.998	0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)	0.002	0.998	0.000
Z01.8 Other specified special examinations	0.002	0.998	0.000
T45.4 Iron and its compounds	0.000	0.998	0.002
M49.59 Collapsed vertebra in diseases classified elsewhere (Site unspecified)	0.002	0.998	0.000
M49.58 Collapsed vertebra in diseases classified elsewhere (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M49.57 Collapsed vertebra in diseases classified elsewhere (Lumbosacral region)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations